Rolipram

N/A

Report date: 2024/03/07 13:13:11
NME

Base Information

Drug NameRolipram
Drug Alias Namerolipramum咯利普兰AdeoZK-62711ME-3167
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsDepressive Disorder, MajorDepressionMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Mental Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Mental HealthNational Institute Of Neurological Disorders And StrokeNational Institute Of Mental Health (Nimh)
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorDepressionMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG